indicating that the clinical benefit observed with manual thrombectomy was not owing to a lower incidence of further intervention. Although the TAPAS trial did not assess infarct size or left ...

The following is a summary of “Comparative Outcomes of Left Main and Non-Left Main Percutaneous Coronary Intervention from ...

"Key predictors of intubation included cardiogenic shock, out-of-hospital cardiac arrest, femoral access, left main disease, ...

Patients who suffer a GI bleed after PCI are a challenging group. They may have multiple comorbidities and are often medically unstable; treatment must balance the need to prevent ischemic post ...

Bisoprolol is clinically feasible option in reducing resting heart rate (RHR) and improving left ventricular ejection ...

Despite angiographically successful primary percutaneous coronary intervention (PCI) in patients with ST-segment elevation myocardial infarction, microcirculatory failure is common and leads to an ...

There are two main options: percutaneous coronary intervention or coronary artery bypass grafting. Percutaneous coronary ...

CHANGES in left ventricular ejection fraction (LVEF) following percutaneous coronary intervention (PCI) differ based on ...

PhilHealth has significantly increased its coverage for Ischemic Heart Disease-Acute Myocardial Infarction (IHD-AMI) or "heart attack," providing expanded financial support for patients and ...

Safe aspirin elimination in patients with HeartMate 3 LVAD reduces bleeding risk, offering key clinical practice insights.